Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Borderline hypokalaemia
Cardiovascular disease
Low normal potassium
Journal
European heart journal. Cardiovascular pharmacotherapy
ISSN: 2055-6845
Titre abrégé: Eur Heart J Cardiovasc Pharmacother
Pays: England
ID NLM: 101669491
Informations de publication
Date de publication:
03 11 2021
03 11 2021
Historique:
received:
27
12
2020
accepted:
04
05
2021
pubmed:
7
5
2021
medline:
31
3
2022
entrez:
6
5
2021
Statut:
ppublish
Résumé
Hypokalaemia is common in patients with cardiovascular disease. In this review, we emphasize the importance of tight potassium regulation in patients with cardiovascular disease based on findings from observational studies. To enhance the understanding, we also describe the mechanisms of potassium homeostasis maintenance, the most common causes of hypokalaemia and present strategies for monitoring and management of low potassium levels. We propose elevation of potassium in asymptomatic patients with lower normal concentrations and concurrent cardiovascular disease. These proposals are intended to assist clinicians until more evidence is available.
Identifiants
pubmed: 33956964
pii: 6270921
doi: 10.1093/ehjcvp/pvab038
doi:
Substances chimiques
Potassium
RWP5GA015D
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
557-567Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.